Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar SIDRWC (< 20) Submitted: 9/28/2011 2:50:23 AM : Outperform Start Price: $67.62 ALXN Score: +23.53

The long-term potential growth for this company is astronomical... They seem to have incredible moment at this point, and is closely linked to stock-market turbulence. Very excited for this companies potential, and am buying in for the long hall.

Featured Broker Partners


Advertisement